New York Health Care (OTCMKTS:BBAL – Get Free Report) and Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.
Analyst Ratings
This is a breakdown of current ratings and price targets for New York Health Care and Fresenius SE & Co., as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
New York Health Care | 0 | 0 | 0 | 0 | 0.00 |
Fresenius SE & Co. | 0 | 0 | 2 | 1 | 3.33 |
Given New York Health Care’s higher possible upside, equities research analysts plainly believe New York Health Care is more favorable than Fresenius SE & Co..
Valuation and Earnings
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
New York Health Care | N/A | N/A | N/A | N/A | N/A |
Fresenius SE & Co. | $23.63 billion | N/A | $509.67 million | $0.53 | 25.72 |
Fresenius SE & Co. has higher revenue and earnings than New York Health Care.
Profitability
This table compares New York Health Care and Fresenius SE & Co.’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
New York Health Care | N/A | N/A | N/A |
Fresenius SE & Co. | 5.09% | 9.33% | 4.31% |
Summary
Fresenius SE & Co. beats New York Health Care on 7 of the 8 factors compared between the two stocks.
About New York Health Care
New York Health Care, Inc. operates as a home care services agency primarily in New York. The company offers various home care services, such as companionship services, homemaker/housekeeper staff, professional and practical nurses, home health aides, care givers, geriatric care, and dementia and alzheimer care services. It also provides insurance services. The company was founded in 1983 and is based in Valley Stream, New York.
About Fresenius SE & Co.
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Receive News & Ratings for New York Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for New York Health Care and related companies with MarketBeat.com's FREE daily email newsletter.